Literature DB >> 31034924

The AP-1 transcriptional complex: Local switch or remote command?

Fabienne Bejjani1, Emilie Evanno2, Kazem Zibara3, Marc Piechaczyk4, Isabelle Jariel-Encontre5.   

Abstract

The ubiquitous family of AP-1 dimeric transcription complexes is involved in virtually all cellular and physiological functions. It is paramount for cells to reprogram gene expression in response to cues of many sorts and is involved in many tumorigenic processes. How AP-1 controls gene transcription has largely remained elusive till recently. The advent of the "omics" technologies permitting genome-wide studies of transcription factors has however changed and improved our view of AP-1 mechanistical actions. If these studies confirm that AP-1 can sometimes act as a local transcriptional switch operating in the vicinity of transcription start sites (TSS), they strikingly indicate that AP-1 principally operates as a remote command binding to distal enhancers, placing chromatin architecture dynamics at the heart of its transcriptional actions. They also unveil novel constraints operating on AP-1, as well as novel mechanisms used to regulate gene expression via transcription-pioneering-, chromatin-remodeling- and chromatin accessibility maintenance effects.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AP-1; Enhancer; Fos; Jun; Promoter; Transcription

Mesh:

Substances:

Year:  2019        PMID: 31034924     DOI: 10.1016/j.bbcan.2019.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  48 in total

Review 1.  Oxidative Stress in Cancer.

Authors:  John D Hayes; Albena T Dinkova-Kostova; Kenneth D Tew
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

2.  High-Resolution Mapping of Multiway Enhancer-Promoter Interactions Regulating Pathogen Detection.

Authors:  Pranitha Vangala; Rachel Murphy; Sofia A Quinodoz; Kyle Gellatly; Patrick McDonel; Mitchell Guttman; Manuel Garber
Journal:  Mol Cell       Date:  2020-09-28       Impact factor: 17.970

Review 3.  Picornaviruses and RNA Metabolism: Local and Global Effects of Infection.

Authors:  Autumn C Holmes; Bert L Semler
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  ACS Chem Neurosci       Date:  2022-01-12       Impact factor: 4.418

5.  MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.

Authors:  Atrayee Bhattacharya; Atsushi Fushimi; Nami Yamashita; Masayuki Hagiwara; Yoshihiro Morimoto; Hasan Rajabi; Mark D Long; Maha Abdulla; Rehan Ahmad; Kelly Street; Song Liu; Tao Liu; Donald Kufe
Journal:  Mol Cancer Res       Date:  2022-04-01       Impact factor: 5.852

Review 6.  The Mediator kinase module: an interface between cell signaling and transcription.

Authors:  Olivia Luyties; Dylan J Taatjes
Journal:  Trends Biochem Sci       Date:  2022-02-19       Impact factor: 13.807

Review 7.  Epigenomic and enhancer dysregulation in uterine leiomyomas.

Authors:  Oliwia W Mlodawska; Priyanka Saini; J Brandon Parker; Jian-Jun Wei; Serdar E Bulun; Melissa A Simon; Debabrata Chakravarti
Journal:  Hum Reprod Update       Date:  2022-06-30       Impact factor: 17.179

8.  Molecular mechanism of methyl-dependent and spatial-specific DNA recognition of c-Jun homodimer.

Authors:  Li-Hua Bie; Jun-Wen Fei; Jun Gao
Journal:  J Mol Model       Date:  2021-07-15       Impact factor: 1.810

9.  Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project.

Authors:  Erasmo Zamarrón-Licona; José Manuel Rodríguez-Pérez; Rosalinda Posadas-Sánchez; Gilberto Vargas-Alarcón; Manuel Alfonso Baños-González; Verónica Marusa Borgonio-Cuadra; Nonanzit Pérez-Hernández
Journal:  Diagnostics (Basel)       Date:  2021-04-26

Review 10.  A Driver Never Works Alone-Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer.

Authors:  Maria Grzes; Magdalena Oron; Zuzanna Staszczak; Akanksha Jaiswar; Magdalena Nowak-Niezgoda; Dawid Walerych
Journal:  Cancers (Basel)       Date:  2020-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.